BCL2 interacting protein 3 pseudogene 14 (BNIP3P14)

BCL2 interacting protein 3 pseudogene 14 (BNIP3P14) is officially classified as a pseudogene by the HUGO Gene Nomenclature Committee (HGNC). It does not encode a functional protein and is not considered a therapeutic target. While some related pseudogenes may possess RNA-mediated regulatory functions, there is no evidence that BNIP3P14 has any established function, biomarker utility, or disease association. The functional protein in the BNIP3 family, BNIP3, is a pro-apoptotic member of the Bcl-2 family involved in cell death regulation, but BNIP3P14 does not encode this protein or have any similar role[1][2][5][7]. Summary: BNIP3P14 is a pseudogene with no direct biological, therapeutic, or clinical relevance as a protein target. If a therapeutic target is intended, this entry is incorrect and likely refers to the active BNIP3 gene/protein (not BNIP3P14)[1][6].

Other names

BCL2/adenovirus E1B 19kDa interacting protein 3 pseudogene 14BNIP3P14100421696 (NCBI Gene)ENSG00000274612 (Ensembl)